---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-154347"
form_type: "8-K"
ticker: "RPRX"
cik: "0001802768"
company_name: "Royalty Pharma plc"
filed_at: "2024-06-04T23:59:59+00:00"
generated_at: "2026-06-01T06:35:25.236218+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Royalty Pharma prices $1.5B senior notes offering across three tranches

## Summary
- Issued $500M 5.150% Senior Notes due 2029, $500M 5.400% due 2034, and $500M 5.900% due 2054.
- Notes are senior unsecured and guaranteed by Royalty Pharma Holdings Ltd.
- Offering expected to close on June 10, 2024, subject to customary conditions.
- Underwriting agreement with BofA, Citigroup, J.P. Morgan, Morgan Stanley, and TD Securities.

## SEC filing metadata
- accession: 0001193125-24-154347
- form_type: 8-K
- ticker: RPRX
- cik: 0001802768
- company_name: Royalty Pharma plc
- filed_at: 2024-06-04T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1802768/000119312524154347/0001193125-24-154347-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1802768/000119312524154347/d821949d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-154347
- JSON: https://secwatch.observer/filing/0001193125-24-154347.json
- Plain text: https://secwatch.observer/filing/0001193125-24-154347.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.